These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9243111)

  • 1. Aspirin therapy in diabetes mellitus.
    Colwell JA
    Diabetologia; 1997 Jul; 40(7):867. PubMed ID: 9243111
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin: not currently for primary prevention in diabetes.
    Jackson G
    Int J Clin Pract; 2009 Jun; 63(6):831-2. PubMed ID: 19490189
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin as antiplatelet agent in diabetes: Cons.
    Mannucci PM
    Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and gastrointestinal toxicity.
    Törüner M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tighter aspirin control urged for patients with diabetes. Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.
    Heart Advis; 2010 Aug; 13(8):6. PubMed ID: 22792576
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin in type 2 diabetes: is there any evidence base?
    Walsh M; Spurling G
    BMJ; 2008 Oct; 337():a1902. PubMed ID: 18927174
    [No Abstract]   [Full Text] [Related]  

  • 7. Enteric coated aspirin.
    Grossman CM
    Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin and clopidogrel resistance in patients with diabetes mellitus.
    Scheen AJ; Legrand D
    Eur Heart J; 2006 Dec; 27(23):2900; author reply 2900-1. PubMed ID: 17015405
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of aspirin resistance in patients with type 2 diabetes.
    Fateh-Moghadam S; Plöckinger U; Cabeza N; Htun P; Reuter T; Ersel S; Gawaz M; Dietz R; Bocksch W
    Acta Diabetol; 2005 Jun; 42(2):99-103. PubMed ID: 15944844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic use of acetylsalicylic acid in diabetics].
    Zácková V
    Vnitr Lek; 2003 Dec; 49(12):972-5. PubMed ID: 15040166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Should one prescribe aspirin for all diabetics?].
    Passa P
    Diabetes Metab; 1997 Dec; 23(6):554-6. PubMed ID: 9496565
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary vascular prevention: The end of the road for aspirin?
    Ajjan RA
    Diab Vasc Dis Res; 2018 Nov; 15(6):475-476. PubMed ID: 30415566
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin for primary prevention of cardiovascular events in diabetes: still an open question.
    Nicolucci A
    JAMA; 2008 Nov; 300(18):2180-1. PubMed ID: 18997199
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
    Takada M; Fukumoto K; Shibakawa M
    J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering the benefits of aspirin.
    Johns Hopkins Med Lett Health After 50; 2007 Feb; 18(12):3. PubMed ID: 17340747
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetes mellitus: use of aspirin (AAS)].
    Lima JG; Góis LT; Nóbrega LH
    Rev Assoc Med Bras (1992); 2005; 51(4):188-9. PubMed ID: 16127574
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus.
    Rhee SY; Kim YS; Chon S; Oh S; Woo JT; Kim SW; Kim JW
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e11-4. PubMed ID: 20934769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.